{"disease":{"id":"schizoaffective-disorder","name":"schizoaffective disorder"},"drugs":{"marketed":[{"drug_id":"paliperidone","indication_name":"Schizoaffective Disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"PALIPERIDONE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"Atypical Antipsychotic [EPC]","quality_score":20,"revenue":null,"mechanism":null},{"drug_id":"clozapine","indication_name":"Suicidal Behavior in Schizoaffective Disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Clozaril","generic_name":"CLOZAPINE","company_name":"Jazz Pharmaceuticals","drug_phase":"marketed","molecular_target":"D2, 5-HT2A","drug_class":"Atypical Antipsychotic [EPC]","quality_score":69,"revenue":null,"mechanism":"Clozapine's efficacy in schizophrenia may be due to its antagonism of D2 and 5-HT2A receptors."},{"drug_id":"clozaril","indication_name":"Suicidal Behavior in Schizoaffective Disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Clozaril","company_name":"Dong Wha Pharmaceutical Co. Ltd.","drug_phase":"phase_1","molecular_target":"Aldehyde oxidase, UDP-glucuronosyltransferase 1-4, 5-hydroxytryptamine receptor 1E","drug_class":"","quality_score":12,"revenue":null,"mechanism":""},{"drug_id":"fazaclo","indication_name":"Suicidal Behavior in Schizoaffective Disorder","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Fazaclo","company_name":"Manhattan Psychiatric Center","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, UDP-glucuronosyltransferase 1-4, 5-hydroxytryptamine receptor 1E","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":4,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07005245","title":"Survey on the Reproductive and Child-Rearing Situations of Patients With Severe Mental Disorders","phase":"","overall_status":"COMPLETED","enrollment_count":77145,"lead_sponsor_name":"Peking University","has_results":false},{"nct_id":"NCT00001486","title":"Genetic Study of Schizophrenia","phase":"","overall_status":"COMPLETED","enrollment_count":4914,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT00001198","title":"Evaluating Genetic Risk Factors for Childhood-Onset Schizophrenia","phase":"","overall_status":"TERMINATED","enrollment_count":1556,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT00212784","title":"Efficacy and Safety of Asenapine Using an Active Control in Subjects With Schizophrenia or Schizoaffective Disorder (25517)(P05935)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1225,"lead_sponsor_name":"Organon and Co","has_results":false},{"nct_id":"NCT04580134","title":"CLOZAPINE Response in Biotype-1","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":524,"lead_sponsor_name":"University of Texas Southwestern Medical Center","has_results":false},{"nct_id":"NCT05658510","title":"Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":452,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":false},{"nct_id":"NCT04268303","title":"Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":380,"lead_sponsor_name":"BioXcel Therapeutics Inc","has_results":true},{"nct_id":"NCT03240380","title":"Joint Crisis Plans or Crisis Cards for People With Severe Mental Disorders to Reduce Coercion in Psychiatric Care.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":374,"lead_sponsor_name":"Universitätsklinikum Hamburg-Eppendorf","has_results":false},{"nct_id":"NCT05030272","title":"Comparing Two Behavioral Approaches to Quitting Smoking in Mental Health Settings","phase":"NA","overall_status":"COMPLETED","enrollment_count":343,"lead_sponsor_name":"Wake Forest University Health Sciences","has_results":false},{"nct_id":"NCT06740383","title":"Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services","phase":"","overall_status":"RECRUITING","enrollment_count":320,"lead_sponsor_name":"Beth Israel Deaconess Medical Center","has_results":false},{"nct_id":"NCT04068467","title":"Evaluation of mHealth for Serious Mental Illness","phase":"NA","overall_status":"COMPLETED","enrollment_count":315,"lead_sponsor_name":"University of Washington","has_results":false},{"nct_id":"NCT05934474","title":"Biocollection on Peripheral Inflammation","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Nantes University Hospital","has_results":false},{"nct_id":"NCT04512066","title":"A Trial of the Efficacy and the Safety of RO6889450 (Ralmitaront) vs Placebo in Patients With an Acute Exacerbation of Schizophrenia or Schizoaffective Disorder","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":287,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT00942981","title":"Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission Tomography","phase":"","overall_status":"COMPLETED","enrollment_count":283,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT05208190","title":"Clozapine for the Prevention of Violence in Schizophrenia: a Randomized Clinical Trial","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":280,"lead_sponsor_name":"New York State Psychiatric Institute","has_results":false},{"nct_id":"NCT05273164","title":"State Representation in Early Psychosis","phase":"","overall_status":"COMPLETED","enrollment_count":277,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT03559426","title":"Research Into Antipsychotic Discontinuation and Reduction Trial","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":253,"lead_sponsor_name":"University College, London","has_results":false},{"nct_id":"NCT03050853","title":"The Appeal and Impact of E-cigarettes in Smokers With SMI","phase":"NA","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":false},{"nct_id":"NCT03848234","title":"Estradiol Patch as add-on to Antipsychotics in Patients With Schizophrenia, Schizoaffective or Schizophreniform Disorder","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":209,"lead_sponsor_name":"Tangent Data","has_results":false},{"nct_id":"NCT03829280","title":"Cognitive Adaption Training-Effectiveness in Real-world Settings and Mechanism of Action (CAT-EM)","phase":"NA","overall_status":"COMPLETED","enrollment_count":205,"lead_sponsor_name":"The University of Texas Health Science Center at San Antonio","has_results":false},{"nct_id":"NCT07098169","title":"Randomized Clinical Trial of iTEST: A Blended Intervention Targeting Introspective Accuracy","phase":"NA","overall_status":"RECRUITING","enrollment_count":201,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT05877716","title":"EPI-MINN: Targeting Cognition and Motivation - National","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":200,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT04554121","title":"Efficacy of Personalizing Cognitive Remediation for Schizophrenia by Targeting Impairments in Early Auditory Processing","phase":"NA","overall_status":"COMPLETED","enrollment_count":194,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT04298450","title":"ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention","phase":"NA","overall_status":"COMPLETED","enrollment_count":186,"lead_sponsor_name":"Centre for Addiction and Mental Health","has_results":false},{"nct_id":"NCT05824117","title":"Enhancing Educational and Vocational Recovery in Adolescents and Young Adults With Early Psychosis Through Supported Employment and Education.","phase":"NA","overall_status":"UNKNOWN","enrollment_count":184,"lead_sponsor_name":"Charite University, Berlin, Germany","has_results":false},{"nct_id":"NCT00057707","title":"Effects of Modafinil on Brain Function in Patients With Schizophrenia","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":176,"lead_sponsor_name":"National Institute of Mental Health (NIMH)","has_results":false},{"nct_id":"NCT03049813","title":"Virtual Reality Job Interview Training in Severe Mental Illness","phase":"NA","overall_status":"COMPLETED","enrollment_count":168,"lead_sponsor_name":"University of Michigan","has_results":true},{"nct_id":"NCT03390491","title":"OnTrack>An Online Role-Playing Game for Young People With First Episode Psychosis","phase":"NA","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Center for Social Innovation, Massachusetts","has_results":false},{"nct_id":"NCT06423651","title":"Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders","phase":"NA","overall_status":"RECRUITING","enrollment_count":160,"lead_sponsor_name":"Universitat Autonoma de Barcelona","has_results":false},{"nct_id":"NCT05538832","title":"Remote State Representation in Early Psychosis","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":152,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT02815813","title":"Lifestyle Intervention for Young Adults With Serious Mental Illness","phase":"NA","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":true},{"nct_id":"NCT01952041","title":"A New Paradigm for Illness Monitoring and Relapse Prevention in Schizophrenia","phase":"NA","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Dartmouth-Hitchcock Medical Center","has_results":true},{"nct_id":"NCT02453217","title":"The Potential Efficacy of the Chinese Health Improvement Profile- A Pilot Clustered Randomised Controlled Trial","phase":"NA","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"Wai-Tong Chien","has_results":false},{"nct_id":"NCT07086040","title":"Effects of RAS in SZ","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":140,"lead_sponsor_name":"Shu-Mei Wang","has_results":false},{"nct_id":"NCT01542229","title":"PTSD (PostTraumatic Stress Disorder) Services for Veterans With SMI (Severe Mental Illness)","phase":"NA","overall_status":"COMPLETED","enrollment_count":134,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT03669640","title":"A Study to Assess the Effects of RO6889450 (Ralmitaront) in Participants With Schizophrenia or Schizoaffective Disorder and Negative Symptoms","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":131,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT06182787","title":"Development of a Model for Digital Monitoring of the Mental State of the Hospitalized Patient","phase":"","overall_status":"RECRUITING","enrollment_count":130,"lead_sponsor_name":"Sheba Medical Center","has_results":false},{"nct_id":"NCT06865937","title":"Context-Aware Mobile Intervention for Social Recovery in Serious Mental Illness (R33)","phase":"NA","overall_status":"RECRUITING","enrollment_count":125,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT05416658","title":"Shared Decision Making for Antipsychotic Medications","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"New York State Psychiatric Institute","has_results":false},{"nct_id":"NCT04144231","title":"Cognitive Behavioral Therapy for Insomnia (CBT-I) in Schizophrenia(SLEEPINS)","phase":"NA","overall_status":"UNKNOWN","enrollment_count":120,"lead_sponsor_name":"Helsinki University Central Hospital","has_results":false},{"nct_id":"NCT03974620","title":"Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Pakistan Institute of Living and Learning","has_results":false},{"nct_id":"NCT07447960","title":"LRFN5 and OLFM4 in Schizoaffective Disorder","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":120,"lead_sponsor_name":"Elazığ Mental Health and Diseases Hospital","has_results":false},{"nct_id":"NCT06898879","title":"Enhancing Veteran-Clinical Collaboration in VA PRRCs","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":119,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT05670197","title":"Service User and Staff Views on Digital Remote Monitoring for Psychosis","phase":"","overall_status":"COMPLETED","enrollment_count":118,"lead_sponsor_name":"Manchester Academic Health Science Centre","has_results":false},{"nct_id":"NCT03930251","title":"Cognitive Remediation for Coordinated Specialty Care","phase":"NA","overall_status":"SUSPENDED","enrollment_count":117,"lead_sponsor_name":"New York State Psychiatric Institute","has_results":false},{"nct_id":"NCT03621774","title":"Mobile CBT for Negative Symptoms","phase":"NA","overall_status":"COMPLETED","enrollment_count":112,"lead_sponsor_name":"University of California, San Diego","has_results":false},{"nct_id":"NCT05157620","title":"Exercise-based Program for Rehabilitation of Veterans With Severe Mental Illness","phase":"NA","overall_status":"RECRUITING","enrollment_count":112,"lead_sponsor_name":"VA Office of Research and Development","has_results":false},{"nct_id":"NCT02782442","title":"Cognitive Training Delivered Remotely to Individuals With Psychosis (ROAM)","phase":"NA","overall_status":"COMPLETED","enrollment_count":109,"lead_sponsor_name":"University of Minnesota","has_results":false},{"nct_id":"NCT06319170","title":"Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":106,"lead_sponsor_name":"Teva Branded Pharmaceutical Products R&D LLC","has_results":true},{"nct_id":"NCT06562608","title":"Anticholinergic Deprescription in Schizophrenia","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":105,"lead_sponsor_name":"Deepak K. Sarpal, M.D.","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}